-
2,2'-Bibenzo[d][1,3,2]dioxaborole
-
BD1373713826-27-298% HPLC
-
¥174.025g
-
BCAT-IN-1
-
BD014638521875078-61-798%
-
¥2329.0250mg
-
2-((4-Chloro-2,6-difluorobenzyl)amino)-7-oxo-5-propyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile
-
BD013574331800024-45-698%
-
¥4516.0100mg
-
(3R)-3-(4-Chloro-3-(o-tolyloxy)naphthalen-1-yl)-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione
-
BD021943912639638-66-595%
-
¥
-
2-(4-Bromobutyl)benzo[d][1,3,2]dioxaborole
-
BD231623142172-51-895+%
-
¥1108.01g
-
BAY-771
-
BD018801732771756-82-098%
-
¥
-
Sodium 4-methyl-5-oxohexanoate
-
BD016280461415683-79-298%
-
¥3294.050mg
-
2-(2-(4-(Hydroxymethyl)phenyl)benzo[d][1,3,2]dioxaborol-5-yl)acetic acid
-
BD01414723N/A95%
-
¥
-
2-(1-Bromoethyl)benzo[d][1,3,2]dioxaborole
-
BD01581249155956-31-395%
-
¥
-
BcATc Inhibitor 2
-
BD01145948406191-34-299+%
-
¥
-
3-(4-Chloro-3-(o-tolyloxy)naphthalen-1-yl)-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione-iso-2
-
BD021856022639638-67-695%
-
¥
-
(4-(5-(2-Aminoethyl)benzo[d][1,3,2]dioxaborol-2-yl)phenyl)methanol
-
BD01384000N/A95%
-
¥